Price Alert

Journey Medical Corporati... (DERM)

NASDAQ: DERM · Real-Time Price · USD

7.47

0.39 (5.51%)

At close: Aug 22, 2025, 3:59 PM

7.47

0.00%

After-hours: Aug 22, 2025, 04:10 PM EDT

5.51% (1D)

Bid	7.4
Market Cap	182.11M
Revenue (ttm)	56.4M
Net Income (ttm)	-8.74M
EPS (ttm)	-0.37
PE Ratio (ttm)	-20.19
Forward PE	8.85
Analyst	Strong Buy

Ask	7.55
Volume	230,562
Avg. Volume (20D)	161,985
Open	7.08
Previous Close	7.08
Day's Range	7.08 - 7.53
52-Week Range	3.54 - 8.90
Beta	0.81

About DERM

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol DERM

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for DERM stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Earnings Surprise

Journey Medical has released their quartely earnings on Aug 12, 2025:

Revenue of $15.01M exceeds estimates by $186.75K, with 1.04% YoY growth.

EPS of -0.16 misses estimates by -0.09, with 5.88% YoY growth.

Next Earnings Release

Journey Medical Corporation is scheduled to release its earnings on Nov 11, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

1 week ago

+8.51%

Journey Medical shares are trading lower after the... Unlock content with Pro Subscription

3 months ago

+18.93%

Journey Medical shares are trading higher after the company reported better-than-expected Q1 financial results.

News

1 week ago · benzinga.com

CoreWeave, CAVA Group, Journey Medical And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

U.S. stock futures were higher this morning, with the Dow futures gaining more than 100 points on Wednesday.

1 week ago · seekingalpha.com

Journey Medical Corporation (DERM) Q2 2025 Earnings Call Transcript

Journey Medical Corporation (NASDAQ:DERM ) Q2 2025 Earnings Conference Call August 12, 2025 4:30 PM ET Company Participants Claude Maraoui - Founder, President, CEO & Director Jaclyn Jaffe - Senior Di...

1 week ago · zacks.com

Journey Medical Corporation (DERM) Reports Q2 Loss, Beats Revenue Estimates

Journey Medical Corporation (DERM) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to a loss of $0.17 per share a year ago.

1 week ago · zacks.com

3 Biotech Stocks Likely to Outpace Q2 Earnings Estimates

Zevra, Inovio and Journey Medical are set for potential earnings beat this week, backed by strong products and positive ESP scores.

2 weeks ago · zacks.com

Journey Medical Corporation (DERM) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release

Journey Medical (DERM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.